mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-07 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
5e-07 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |